Enhancement of the in vitro and in vivo activities of clarithromycin against Haemophilus influenzae by 14-hydroxy-clarithromycin, its major metabolite in humans.

MICs of clarithromycin and its major human metabolite, 14-hydroxy-clarithromycin, for Haemophilus influenzae in combination were reduced two- to fourfold compared with the MICs of each compound alone. Serum reduced the MICs of the parent compound and metabolite two- to fourfold compared with the MIC...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Hardy, D J, Swanson, R N, Rode, R A, Marsh, K, Shipkowitz, N L, Clement, J J
Format: Artigo
Langue:Inglês
Publié: 1990
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC175991/
https://ncbi.nlm.nih.gov/pubmed/2143642
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires